Statistics for Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: Experience in Turkey

Total visits

views
Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: Experience in Turkey 0

Total visits per month

views
May 2024 0
June 2024 0
July 2024 0
August 2024 0
September 2024 0
October 2024 0
November 2024 0

File Visits

views
Özkocaman_vd_2015.pdf 7